Selection criteria for early breast cancer patients in the DBCG proton trial – The randomised phase III trial strategy

BACKGROUND AND PURPOSE: Adjuvant radiotherapy of internal mammary nodes (IMN) improves survival in high-risk early breast cancer patients but inevitably leads to more dose to heart and lung. Target coverage is often compromised to meet heart/lung dose constraints. We estimate heart and lung dose whe...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Clin Transl Radiat Oncol
Hlavní autoři: Stick, Line Bjerregaard, Lorenzen, Ebbe Laugaard, Yates, Esben Svitzer, Anandadas, Carmel, Andersen, Karen, Aristei, Cynthia, Byrne, Orla, Hol, Sandra, Jensen, Ingelise, Kirby, Anna M., Kirova, Youlia M., Marrazzo, Livia, Matías-Pérez, Angela, Nielsen, Mette Marie Bruun, Nissen, Henrik Dahl, Oliveros, Sileida, Verhoeven, Karolien, Vikström, Johan, Offersen, Birgitte Vrou
Médium: Artigo
Jazyk:Inglês
Vydáno: Elsevier 2021
Témata:
Original Research Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7892790/
https://ncbi.nlm.nih.gov/pubmed/33659716
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ctro.2021.01.012
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky